Your browser doesn't support javascript.
loading
Expression of progesterone-induced blocking factor in severe preeclampsia and its association with immune tolerance imbalance / 南方医科大学学报
Journal of Southern Medical University ; (12): 848-851, 2015.
Artigo em Chinês | WPRIM | ID: wpr-355271
ABSTRACT
<p><b>OBJECTIVE</b>To explore progesterone-induced blocking factor (PIBF) expression in the placenta and blood of patients with severe preeclampsia and its relationship with immune tolerance imbalance.</p><p><b>METHODS</b>Forty-seven patients admitted between January and December, 2012 were enrolled in this study, including 25 patients with early-onset severe preeclampsia (EOPE) and 22 with late-onset severe preeclampsia (LOPE), with 25 women with normal pregnancy serving as control group. The antenatal blood and postpartum placenta were collected for immunohistochemical staining to detect PIBF expression in the placenta and for testing serum PIBF level using ELISA. Flow cytometry was used to detect the percentage of circulating Th1 and Th2 cells and the Th1/Th2 ratio was calculated.</p><p><b>RESULTS</b>PIBF was expressed in decidual cells, syncytiotrophoblasts and partial cytotrophablasts. The serum PIBF levels were 213.58 ± 44.93 ng/ml in EOPE group, 243.00∓61.19 ng/ml in LOPE group and 273.91 ± 48.57 ng/ml in control group. There were significant differences in serum PIBF, blood Th1/Th2 and placenta PIBF-IOD among the 3 groups (P<0.05). EOPE group had significantly lower serum PIBF, lower llacental PIBF quantity (PIBF-IOD) and higher blood Th1/Th2 than the control group (P<0.05). Serum PIBF in women with severe preeclampsia was positively correlated with placenta PIBF-IOD and negatively with blood Th1/Th2 ratio (P<0.05), but a negative correlation between serum PIBF and 24-hour urinary protein was found only in EOPE group (P<0.05).</p><p><b>CONCLUSION</b>The immune tolerance imbalance mediated by PIBF may participate in the pathogenesis of severe preeclampsia. PIBF, the immune suppressor secreted by lymphocytes of pregnancy women, is also a protective factor against severe preeclampsia, which is expected to be a new target in therapy.</p>
Assuntos
Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Placenta / Pré-Eclâmpsia / Proteínas da Gravidez / Sangue / Ensaio de Imunoadsorção Enzimática / Estudos de Casos e Controles / Fatores Supressores Imunológicos / Alergia e Imunologia / Equilíbrio Th1-Th2 / Tolerância Imunológica Tipo de estudo: Estudo observacional / Fatores de risco Limite: Feminino / Humanos / Gravidez Idioma: Chinês Revista: Journal of Southern Medical University Ano de publicação: 2015 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Placenta / Pré-Eclâmpsia / Proteínas da Gravidez / Sangue / Ensaio de Imunoadsorção Enzimática / Estudos de Casos e Controles / Fatores Supressores Imunológicos / Alergia e Imunologia / Equilíbrio Th1-Th2 / Tolerância Imunológica Tipo de estudo: Estudo observacional / Fatores de risco Limite: Feminino / Humanos / Gravidez Idioma: Chinês Revista: Journal of Southern Medical University Ano de publicação: 2015 Tipo de documento: Artigo